台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

MP06-09: Anal sphincter length and power are associated with early continent after radical prostatectomy

2021-05-24 • 觀看: 1441 • 回應: 0 • doc
MP06-08: Serum vitamin D levels in females with urinary incontinence: a meta-analysis of observational trials

2021-05-24 • 觀看: 1392 • 回應: 0 • doc
MP06-07: XX male syndrome : A rare cause of male infertility, case analysis in a tertiary fertility service

2021-05-24 • 觀看: 1828 • 回應: 0 • doc
MP06-06: Comparing the outcomes and effectiveness of robotic-assisted sacrocolpopexy and laparoscopic sacrocolpopexy in the treatment of pelvic organ prolapse

2021-05-24 • 觀看: 1462 • 回應: 0 • doc
MP06-05: The video urodynamic characteristics in SCI patients with different injury level and bladder condition

2021-05-24 • 觀看: 1568 • 回應: 0 • doc
MP06-04: Urethra-sphincter complex volume predictive of residual diverticulum after diverticulectomy

2021-05-24 • 觀看: 1428 • 回應: 0 • doc
MP06-03: Routine use of prophylactic metoclopramide after transperitoneal robotic-assisted radical prostatectomy: really needed?

2021-05-24 • 觀看: 1476 • 回應: 0 • doc
MP06-02: The senhance robotic system is feasible in oncologic and non-oncologic urologic surgeries: initial experiences and troubleshooting of new system

2021-05-24 • 觀看: 2060 • 回應: 0 • doc
MP06-01: Impact of obesity on the outcome of prostate cancer post robot-assisted radical prostatectomy

2021-05-24 • 觀看: 1489 • 回應: 0 • doc
MP05-10: Results of bevacizumab plus erlotinib in patients with metastatic type 2 papillary renal cell cancer - experience in Taipei Veterans General Hospital

2021-05-24 • 觀看: 2255 • 回應: 0 • doc
MP05-09: Glutathione s-transferase Mu 5 plays anti-tumor activity in bladder cancer cells

2021-05-24 • 觀看: 1461 • 回應: 0 • doc
MP05-08: Anti-cancer effects and tumor marker role of glutathione s-transferase mu 5 in human bladder cancer

2021-05-24 • 觀看: 1459 • 回應: 0 • doc

Prev
686
687
688
689
690
691
692
693
694
695
Next
/ 1262